Emkay Global Financial's research report on Gulf Oil Lubricants. We reiterate our positive stance on GOLI, led by steady core volume growth (8% core volume CAGR over FY24-27E, over 2x of industry growth), and a 13- 14% EBITDA margin profile supported by premiumization efforts, brand building, input cost management, and dedicated marketing initiatives.
Open FlipReported Standalone quarterly numbers for Raasi Refractories are: Net Sales at Rs 11.63 crore in September 2024 down 31.19% from Rs. 16.91 crore in September 2023. Quarterly Net Profit at Rs. 0.63 crore in September 2024 down 86.24% from Rs. 4.55 crore in September 2023. EBITDA stands at Rs. 1.45 crore in September 2024 down 72.49% from Rs. 5.27 crore in September 2023.
Open FlipReported Standalone quarterly numbers for Sharma East India Hospital and Medical Research are: Net Sales at Rs 9.02 crore in September 2024 up 68.09% from Rs. 5.36 crore in September 2023. Quarterly Net Profit at Rs. 0.34 crore in September 2024 up 16.89% from Rs. 0.29 crore in September 2023. EBITDA stands at Rs. 1.15 crore in September 2024 up 55.41% from Rs. 0.74 crore in September 2023.
Open Flip